Work

OA05.04 Real-World Progression-Free Survival in Oncogenic Driver-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated With Single-Agent Immunotherapy

Year: 2021

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2020.10.029

Authors: J. Bodor, J. Bauman, E. Handorf, C. Zawislak, E. Ross, M. Clapper, J. Treat

Institution: Fox Chase Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3121092231

Cites:

Cited by: 1

Related to: 10